 Bradford Smith
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventilator-Induced Lung Injury | 20 | 2026 | 61 | 7.610 |
Why?
| | Lung | 34 | 2026 | 4109 | 2.920 |
Why?
| | Positive-Pressure Respiration | 15 | 2026 | 112 | 2.810 |
Why?
| | Acute Lung Injury | 8 | 2026 | 303 | 2.490 |
Why?
| | Respiration, Artificial | 18 | 2025 | 708 | 2.190 |
Why?
| | Respiratory Mechanics | 10 | 2025 | 72 | 1.650 |
Why?
| | Pulmonary Alveoli | 12 | 2025 | 383 | 1.540 |
Why?
| | Lung Injury | 6 | 2026 | 237 | 1.380 |
Why?
| | Computer Simulation | 12 | 2025 | 1026 | 1.280 |
Why?
| | Pulmonary Surfactants | 6 | 2025 | 102 | 1.230 |
Why?
| | Models, Biological | 8 | 2025 | 1822 | 1.040 |
Why?
| | Tidal Volume | 9 | 2025 | 111 | 0.940 |
Why?
| | Ventilators, Mechanical | 4 | 2025 | 70 | 0.780 |
Why?
| | Equipment Design | 3 | 2020 | 530 | 0.660 |
Why?
| | Animals | 40 | 2026 | 38109 | 0.650 |
Why?
| | Continuous Positive Airway Pressure | 3 | 2016 | 88 | 0.620 |
Why?
| | Laryngoscopes | 1 | 2020 | 45 | 0.620 |
Why?
| | Pulmonary Surfactant-Associated Protein B | 3 | 2025 | 7 | 0.620 |
Why?
| | Laryngoscopy | 1 | 2020 | 117 | 0.590 |
Why?
| | Bleomycin | 3 | 2024 | 253 | 0.590 |
Why?
| | Mice | 19 | 2026 | 18365 | 0.560 |
Why?
| | Disease Models, Animal | 13 | 2026 | 4569 | 0.540 |
Why?
| | Bronchopulmonary Dysplasia | 3 | 2026 | 410 | 0.460 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.450 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.440 |
Why?
| | Pulmonary Atelectasis | 3 | 2024 | 16 | 0.440 |
Why?
| | Algorithms | 5 | 2025 | 1839 | 0.440 |
Why?
| | Mice, Inbred BALB C | 5 | 2019 | 1253 | 0.420 |
Why?
| | Pressure | 4 | 2024 | 225 | 0.420 |
Why?
| | Transforming Growth Factor beta1 | 2 | 2026 | 178 | 0.410 |
Why?
| | Mice, Inbred C57BL | 10 | 2026 | 5997 | 0.400 |
Why?
| | Blood-Air Barrier | 2 | 2025 | 12 | 0.390 |
Why?
| | Acetaminophen | 2 | 2026 | 264 | 0.380 |
Why?
| | Rats | 11 | 2026 | 5614 | 0.360 |
Why?
| | Alveolar Epithelial Cells | 4 | 2022 | 120 | 0.340 |
Why?
| | Complex Mixtures | 1 | 2009 | 12 | 0.310 |
Why?
| | Cigarette Smoking | 2 | 2022 | 99 | 0.310 |
Why?
| | Respiratory Function Tests | 4 | 2018 | 547 | 0.300 |
Why?
| | Vitamin D | 2 | 2025 | 400 | 0.300 |
Why?
| | Microfluidics | 1 | 2009 | 62 | 0.300 |
Why?
| | Models, Chemical | 1 | 2009 | 269 | 0.270 |
Why?
| | Rats, Sprague-Dawley | 8 | 2026 | 2540 | 0.270 |
Why?
| | Toll-Like Receptor 9 | 1 | 2026 | 37 | 0.240 |
Why?
| | Inhalation | 1 | 2025 | 29 | 0.230 |
Why?
| | Male | 21 | 2026 | 72406 | 0.220 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2025 | 74 | 0.210 |
Why?
| | Patient Care | 1 | 2025 | 118 | 0.210 |
Why?
| | Tissue Fixation | 1 | 2024 | 37 | 0.210 |
Why?
| | Respiration | 3 | 2019 | 207 | 0.210 |
Why?
| | Leukocytes | 2 | 2022 | 295 | 0.200 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.200 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2023 | 35 | 0.200 |
Why?
| | Stress, Mechanical | 1 | 2025 | 494 | 0.200 |
Why?
| | Cerium | 1 | 2023 | 19 | 0.200 |
Why?
| | Humans | 25 | 2026 | 144957 | 0.200 |
Why?
| | Neutrophil Infiltration | 1 | 2023 | 104 | 0.190 |
Why?
| | Lung Compliance | 2 | 2020 | 42 | 0.190 |
Why?
| | Glycocalyx | 1 | 2022 | 30 | 0.180 |
Why?
| | Endoplasmic Reticulum | 1 | 2024 | 266 | 0.170 |
Why?
| | Glycosaminoglycans | 1 | 2022 | 74 | 0.170 |
Why?
| | Pulmonary Medicine | 1 | 2022 | 79 | 0.170 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2025 | 636 | 0.170 |
Why?
| | Animals, Newborn | 4 | 2026 | 902 | 0.170 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 863 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2025 | 367 | 0.170 |
Why?
| | Biomechanical Phenomena | 4 | 2022 | 842 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2020 | 23 | 0.160 |
Why?
| | Epithelium | 1 | 2021 | 314 | 0.160 |
Why?
| | Proof of Concept Study | 1 | 2020 | 85 | 0.160 |
Why?
| | Nonlinear Dynamics | 2 | 2018 | 95 | 0.160 |
Why?
| | Needles | 1 | 2020 | 62 | 0.160 |
Why?
| | Immunity, Innate | 1 | 2026 | 846 | 0.160 |
Why?
| | Models, Anatomic | 1 | 2020 | 84 | 0.150 |
Why?
| | Surface Tension | 3 | 2025 | 10 | 0.150 |
Why?
| | X-Ray Microtomography | 3 | 2025 | 107 | 0.150 |
Why?
| | Healthy Volunteers | 1 | 2020 | 215 | 0.150 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 1 | 2019 | 9 | 0.150 |
Why?
| | Pulmonary Ventilation | 1 | 2020 | 83 | 0.150 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 275 | 0.150 |
Why?
| | Th17 Cells | 1 | 2020 | 101 | 0.150 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 96 | 0.150 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2026 | 675 | 0.150 |
Why?
| | Hyperoxia | 1 | 2020 | 99 | 0.150 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 398 | 0.140 |
Why?
| | Vitamin D Deficiency | 1 | 2020 | 186 | 0.140 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2018 | 139 | 0.130 |
Why?
| | Sensitivity and Specificity | 2 | 2015 | 1990 | 0.130 |
Why?
| | Signal Transduction | 3 | 2026 | 5233 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2022 | 3415 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 479 | 0.130 |
Why?
| | Mice, Knockout | 4 | 2026 | 3125 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2020 | 368 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 534 | 0.120 |
Why?
| | Elasticity | 2 | 2015 | 184 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 395 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 923 | 0.110 |
Why?
| | Tensile Strength | 1 | 2015 | 96 | 0.110 |
Why?
| | Elastic Modulus | 1 | 2015 | 121 | 0.110 |
Why?
| | Therapy, Computer-Assisted | 1 | 2015 | 64 | 0.110 |
Why?
| | Neutrophils | 1 | 2020 | 1134 | 0.110 |
Why?
| | Endotoxins | 2 | 2026 | 221 | 0.100 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2021 | 691 | 0.100 |
Why?
| | Lung Diseases | 1 | 2020 | 787 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2025 | 1980 | 0.100 |
Why?
| | Biomedical Engineering | 1 | 2012 | 29 | 0.090 |
Why?
| | Doxycycline | 2 | 2025 | 62 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1695 | 0.090 |
Why?
| | Hydrodynamics | 1 | 2011 | 47 | 0.090 |
Why?
| | Pregnancy | 4 | 2026 | 7191 | 0.080 |
Why?
| | Prognosis | 2 | 2022 | 4293 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 710 | 0.080 |
Why?
| | Random Allocation | 3 | 2016 | 363 | 0.080 |
Why?
| | Computer-Aided Design | 1 | 2009 | 40 | 0.080 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 128 | 0.070 |
Why?
| | Female | 11 | 2026 | 78376 | 0.070 |
Why?
| | Asthma | 1 | 2020 | 1768 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2185 | 0.070 |
Why?
| | Rats, Inbred F344 | 2 | 2020 | 268 | 0.070 |
Why?
| | Finite Element Analysis | 1 | 2025 | 67 | 0.060 |
Why?
| | Water-Electrolyte Balance | 1 | 2025 | 36 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2025 | 30 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2852 | 0.060 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 95 | 0.050 |
Why?
| | Methacholine Chloride | 1 | 2024 | 50 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 854 | 0.050 |
Why?
| | Cell Size | 1 | 2024 | 92 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 22453 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 207 | 0.050 |
Why?
| | Biology | 1 | 2023 | 91 | 0.050 |
Why?
| | Biophysics | 1 | 2022 | 74 | 0.040 |
Why?
| | Tyrphostins | 1 | 2021 | 18 | 0.040 |
Why?
| | Amphiregulin | 1 | 2021 | 27 | 0.040 |
Why?
| | Biophysical Phenomena | 1 | 2021 | 68 | 0.040 |
Why?
| | Keratin-5 | 1 | 2021 | 48 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 780 | 0.040 |
Why?
| | Leukosialin | 1 | 2020 | 12 | 0.040 |
Why?
| | Mannose-Binding Lectins | 1 | 2020 | 10 | 0.040 |
Why?
| | Optical Devices | 1 | 2020 | 13 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2020 | 62 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 298 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 65 | 0.040 |
Why?
| | Acinar Cells | 1 | 2019 | 13 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 111 | 0.040 |
Why?
| | Quinazolines | 1 | 2021 | 266 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 11695 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 321 | 0.040 |
Why?
| | Mucin-5B | 1 | 2021 | 234 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2025 | 870 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 984 | 0.040 |
Why?
| | Air | 1 | 2018 | 45 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 428 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.030 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 377 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2021 | 629 | 0.030 |
Why?
| | Eosinophils | 1 | 2020 | 316 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 199 | 0.030 |
Why?
| | Synchrotrons | 1 | 2017 | 13 | 0.030 |
Why?
| | Allergens | 1 | 2020 | 384 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3164 | 0.030 |
Why?
| | Tissue Donors | 1 | 2020 | 424 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 236 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2118 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 2016 | 10 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1718 | 0.030 |
Why?
| | Risk Factors | 2 | 2021 | 10792 | 0.030 |
Why?
| | Rabbits | 1 | 2017 | 648 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2114 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1034 | 0.030 |
Why?
| | Thoracotomy | 1 | 2016 | 83 | 0.030 |
Why?
| | Lung Diseases, Interstitial | 1 | 2022 | 660 | 0.030 |
Why?
| | Airway Resistance | 1 | 2015 | 38 | 0.030 |
Why?
| | Peak Expiratory Flow Rate | 1 | 2014 | 25 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2019 | 590 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2014 | 119 | 0.030 |
Why?
| | Microscopy | 1 | 2016 | 156 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 392 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 195 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2021 | 2832 | 0.020 |
Why?
| | Transcription Factors | 1 | 2021 | 1742 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2365 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3608 | 0.020 |
Why?
| | Fibrosis | 1 | 2015 | 548 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1472 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3335 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2014 | 453 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 35928 | 0.020 |
Why?
| | Surface Properties | 1 | 2011 | 410 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 383 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2880 | 0.020 |
Why?
| | Computational Biology | 1 | 2011 | 681 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2882 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3550 | 0.010 |
Why?
| | Aged | 1 | 2020 | 25947 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40506 | 0.010 |
Why?
|
|
Smith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|